Ennio Cocca Selected Research

acylaminoacyl-peptidase (acylamino-acid-releasing enzyme)

2/2021	Selective inhibition of acylpeptide hydrolase in SAOS-2 osteosarcoma cells: is this enzyme a viable anticancer target?
9/2016	APEH Inhibition Affects Osteosarcoma Cell Viability via Downregulation of the Proteasome.
1/2013	RedOx status, proteasome and APEH: insights into anticancer mechanisms of t10,c12-conjugated linoleic acid isomer on A375 melanoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ennio Cocca Research Topics

Disease

3	Neoplasms (Cancer) 02/2021 - 01/2013
2	Osteosarcoma (Osteogenic Sarcoma) 02/2021 - 09/2016
2	Melanoma (Melanoma, Malignant) 09/2016 - 01/2013
1	Foodborne Diseases 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2017
1	Adenocarcinoma 09/2016

Drug/Important Bio-Agent (IBA)

3	acylaminoacyl-peptidase (acylamino-acid-releasing enzyme)IBA 02/2021 - 01/2013
3	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017 - 01/2013
2	EnzymesIBA 02/2021 - 01/2013
1	Plant ProteinsIBA 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 01/2017
1	Peptides (Polypeptides)IBA 09/2016
1	Proteins (Proteins, Gene)FDA Link 09/2016
1	Messenger RNA (mRNA)IBA 01/2013
1	Glutathione (Reduced Glutathione)IBA 01/2013
1	Linoleic Acid (Linoleate)IBA 01/2013
1	Conjugated Linoleic AcidsIBA 01/2013
1	AntioxidantsIBA 01/2013
1	NF-E2-Related Factor 2IBA 01/2013

Therapy/Procedure

1	Therapeutics 02/2021